| Date Filed | Type | Description |
| 07/21/2023 |
SC 13D/A
| Form SC 13D/A - General statement of acquisition of beneficial ownership: [Amend] |
| 02/07/2023 |
SC 13D/A
| Hudson Executive Capital LP reports a 5% stake in Akoya Biosciences, Inc. |
| 01/20/2023 |
SC 13D/A
| Hudson Executive Capital LP reports a 8.7% stake in ViewRay, Inc. |
| 12/02/2022 |
SC 13D/A
| Form SC 13D/A - General statement of acquisition of beneficial ownership: [Amend] |
| 09/13/2022 |
SC 13D/A
| Hudson Executive Capital LP reports a 9.8% stake in Akoya Biosciences, Inc. |
| 03/23/2022 |
SC 13D/A
| Hudson Executive Capital LP reports a 8.6% stake in Liberated Syndication Inc. |
| 03/11/2022 |
SC 13D/A
| Form SC 13D/A - General statement of acquisition of beneficial ownership: [Amend] |
| 03/09/2022 |
SC 13D/A
| Form SC 13D/A - General statement of acquisition of beneficial ownership: [Amend] |
| 11/17/2021 |
SC 13D/A
| Hudson Executive Capital LP reports a 13.9% stake in Talkspace, Inc. |
| 10/18/2021 |
SC 13D
| Hudson Executive Capital LP reports a 5.6% stake in Akoya Biosciences, Inc. |
| 07/02/2021 |
SC 13D
| Form SC 13D - General statement of acquisition of beneficial ownership: |
| 06/08/2021 |
SC 13D
| Hudson Executive Capital LP reports a 6.8% stake in Liberated Syndication, Inc. |
| 03/11/2021 |
SC 13D/A
| Form SC 13D/A - General statement of acquisition of beneficial ownership: [Amend] |
| 02/26/2021 |
SC 13D/A
| Form SC 13D/A - General statement of acquisition of beneficial ownership: [Amend] |
| 02/19/2021 |
SC 13D
| Form SC 13D - General statement of acquisition of beneficial ownership: |
| 12/15/2020 |
SC 13D/A
| Hudson Executive Capital LP reports a 19.5% stake in Cardtronics plc |
| 12/09/2020 |
SC 13D/A
| Hudson Executive Capital LP reports a 19.5% stake in Cardtronics plc |
| 07/02/2020 |
SC 13D/A
| Form SC 13D/A - General statement of acquisition of beneficial ownership: [Amend] |
| 06/23/2020 |
SC 13D/A
| Form SC 13D/A - General statement of acquisition of beneficial ownership: [Amend] |
| 05/11/2020 |
SC 13D/A
| Hudson Executive Capital LP reports a 9.9% stake in Tivity Health, Inc. |
| 05/06/2020 |
SC 13D/A
| Form SC 13D/A - General statement of acquisition of beneficial ownership: [Amend] |
| 04/27/2020 |
SC 13D/A
| Hudson Executive Capital LP reports a 16.2% stake in USA Technologies, Inc. |
| 03/13/2020 |
SC 13D/A
| Form SC 13D/A - General statement of acquisition of beneficial ownership: [Amend] |
| 02/24/2020 |
SC 13D
| Form SC 13D - General statement of acquisition of beneficial ownership: |
| 02/24/2020 |
SC 13D/A
| Form SC 13D/A - General statement of acquisition of beneficial ownership: [Amend] |
| 02/18/2020 |
SC 13D/A
| Form SC 13D/A - General statement of acquisition of beneficial ownership: [Amend] |
| 01/21/2020 |
SC 13D/A
| Hudson Executive Capital LP reports a 16.3% stake in USA Technologies, Inc. |
| 01/16/2020 |
SC 13D/A
| Hudson Executive Capital LP reports a 2.6% stake in Eagle Pharmaceuticals, Inc. |
| 12/19/2019 |
SC 13D
| Form SC 13D - General statement of acquisition of beneficial ownership: |
| 11/22/2019 |
SC 13D/A
| Hudson Executive Capital LP reports a 16.3% stake in USA Technologies, Inc. |
| 11/18/2019 |
SC 13D/A
| Form SC 13D/A - General statement of acquisition of beneficial ownership: [Amend] |
| 11/04/2019 |
SC 13D/A
| Hudson Executive Capital LP reports a 16.3% stake in USA Technologies, Inc. |
| 10/31/2019 |
SC 13D/A
| Form SC 13D/A - General statement of acquisition of beneficial ownership: [Amend] |
| 10/16/2019 |
SC 13D/A
| Hudson Executive Capital LP reports a 16.3% stake in USA Technologies, Inc. |
|